StockGlow

Eli Lilly and Company (LLYD.BA)

Develops and sells medicines for diabetes, cancer, autoimmune diseases, and Alzheimer's disease.

$22.78+0.02%
Compare LLYD.BA with
StockGlow Score
96
Bullish
BearishBullish
1 year ago+65.7%

The outlook

Eli Lilly trades near its 52-week highs, sitting well above both its 50- and 200-day moving averages. The stock is up substantially from its yearly lows and currently shows strong technical positioning according to available market data.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range97% of the way from its 52-week low to high
Market cap
—
52-wk high
$23.19
52-wk low
$11.20
50-day avg
$21.06
200-day avg
$18.72
Trailing P/E
—

Similar stocks

TMD.BAToyota Motor Corporation$12.89+1.98%MSI.BAMotorola Solutions, Inc.$35,080.00+3.54%ES0105405007.SGAdriano Care Socimi SA$9.85+0.51%EDL.HMEdel SE & Co KGaA$4.78+0.84%1FDX.MIFedEx Corporation$275.50+1.25%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy